![]() |
市场调查报告书
商品编码
1420194
南美洲和中美洲顺势疗法市场预测至 2030 年 - 区域分析 - 按来源、类型、应用和配销通路South & Central America Homeopathy Market Forecast to 2030 - Regional Analysis - by Source, Type, Application, and Distribution Channel |
2022年,中南美洲顺势疗法市场价值为3.2247亿美元,预计2030年将达到9.830亿美元;预计2022年至2030年CAGR为15.0%。
巴西和阿根廷的有利法规推动了南美洲和中美洲顺势疗法市场
在巴西,顺势疗法作为替代医学被广泛使用。顺势疗法于 1840 年由法国顺势疗法医生引进巴西。巴西大约有 15,000 名顺势疗法医生、专业药剂师、兽医和牙医从事这项职业。这总体上简要概述了顺势疗法在巴西的引入时间和技术现状。 2020 年,超过 5,000 万巴西人至少使用过一次顺势疗法药物治疗自己。在巴西,顺势疗法受到 Anvisa 的监管,该机构为药房的生产和处方、工业化和这些药物的销售制定了规则,以保证其品质。工业化顺势疗法药物可以在药局和药局找到,并且必须清楚註明首字母 MS 和始终以数字开头的 8 至 13 个数字序列。此外,还有大量的顺势疗法实验室和药房生产和销售工业化顺势疗法药物。布瓦龙是全球最大的顺势疗法药物实验室,由于该国的需求量很大,开始销售产品。因此,上述因素在预测期内正在推动顺势疗法市场。在阿根廷,顺势疗法得到了公共卫生部的正式认可,因此药房和实验室在与一般疗法相同的控制下製备和销售药物。目前有超过 500 名医师从事统一顺势疗法。老年人口的增加、慢性疾病盛行率的增加以及对顺势疗法药物需求的增加是有助于顺势疗法药物在阿根廷发展的一些因素。根据 IDF 2021 年糖尿病图谱报告,10.5% 的成年人口(20-79 岁)患有糖尿病,其中几乎一半人不知道自己患有这种疾病。根据 LIGA MEDICORUM HOMOEOPATHICA INTERNATIONALIS 的说法,阿根廷的顺势疗法因其众所周知的传统和高学术标准而受到认可。阿根廷的顺势疗法培训由遵循国际顺势疗法联盟 (LMHI) 建议的教育标准的机构保证为医生、牙医、兽医和药剂师提供高级课程。由于阿根廷机构的卓越水平,世界各地经常需要来自阿根廷机构的教师。这表明阿根廷顺势疗法自托马斯·巴勃罗·帕斯切罗博士(LMHI 着名院长)时代以来仍然有效。阿根廷顺势疗法医学协会联合会(FAMHA,即阿根廷顺势疗法医学协会联合会)联合了着名的教育机构,致力于传承这项传统。 FAMHA 继续为顺势疗法的法律认可而奋斗。在这方面,顺势疗法医生可以开立顺势疗法,但这种治疗方法的实践尚未被视为医疗行为。儘管受到卫生系统中保守团体的批评和攻击,但阿根廷的顺势疗法在其他卫生环境中受到所有受益于这种治疗方法的患者的讚赏。
南美洲和中美洲顺势疗法市场概述
南美洲和中美洲顺势疗法市场分为巴西、阿根廷以及南美洲和中美洲其他地区。由于顺势疗法产品和服务的可用性和可及性不断增加,卫生当局加强监管支持以确保顺势疗法产品的销售,市场可能会在预测期内得到推动。
南美洲和中美洲顺势疗法市场收入及 2030 年预测(百万美元)
南美洲和中美洲顺势疗法市场区隔
南美洲和中美洲顺势疗法市场根据来源、类型、应用、配销通路和国家进行细分。根据消息来源,南美洲和中美洲顺势疗法市场分为植物、动物和矿物质。 2022 年,植物细分市场占据最大的市场。
根据类型,南美洲和中美洲顺势疗法市场分为稀释剂、酊剂、生化剂、软膏、片剂等。 2022 年,稀释细分市场占据最大的市场份额。
根据应用,南美洲和中美洲顺势疗法市场分为镇痛和解热、呼吸、神经病学、免疫学、胃肠病学、皮肤病学等。 2022 年,免疫学领域占据最大的市场份额。
根据配销通路,南美洲和中美洲顺势疗法市场分为顺势疗法诊所、零售药局、电子零售商等。 2022 年,顺势疗法诊所细分市场占据最大的市场份额。
根据国家/地区,南美洲和中美洲顺势疗法市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年,巴西在南美洲和中美洲顺势疗法市场份额中占据主导地位。
Fourrts、Boiron、Biologische Heilmittel Heel GmbH、DHU-Arzneimittel GmbH & Co. KG 和 Dr Reckeweg & Co GmbH 是南美洲和中美洲顺势疗法市场的一些领先参与者。
The South & Central America homeopathy market was valued at US$ 322.47 million in 2022 and is expected to reach US$ 983.00 million by 2030; it is estimated to grow at a CAGR of 15.0% from 2022 to 2030.
Favorable Regulations in Brazil and Argentina fuel the South & Central America Homeopathy Market
In Brazil, there is widespread use of homeopathy as an alternative medicine. Homeopathy was introduced to Brazil in 1840 by the French homeopathic physician. There are approximately 15,000 homeopathic physicians, specialized pharmacists, veterinarians, and dental surgeons practicing the profession in Brazil. This generally states a brief overview on when homeopathy was introduced in Brazil and the state of art. In 2020, over 50 million Brazilians had treated themselves with homeopathic medications at least once. In Brazil, homeopathy is regulated by Anvisa, which creates rules for the production and prescription by pharmacies, industrialization, and sale of these medications, in an attempt to guarantee their quality. Industrialized homeopathic medications can be found in pharmacies and drugstores and must clearly state the initials MS and a sequence of 8 to 13 numbers which always start with number. In addition, there are a significant number of homeopathic laboratories and pharmacies producing and selling industrialized homeopathic medicines. Boiron, which is the biggest worldwide laboratory of homeopathic medications started selling its products owing to high demand in the country. Thus, abovementioned factors are driving the homeopathy market during the forecast period. In Argentina, homoeopathic remedies are duly accepted by the Ministry of Public Health, owing to which pharmacies and laboratories prepare and sell their medicines under the same controls as those on general remedies. At present there are more than 500 physicians practicing Unified Homoeopathy. Rise in geriatric population, increase in the prevalence of chronic disorders, and rise in the demand for homeopathy medicines are some factors that will aid the growth of homeopathic medicine in Argentina. As per the IDF Diabetes Atlas 2021 reports, 10.5% of the adult population (20-79 years) has diabetes, with almost half unaware of the condition. According to the LIGA MEDICORUM HOMOEOPATHICA INTERNATIONALIS, homeopathy in Argentina is recognized for its well-known tradition and its high academic standards. Homeopathic training in Argentina is guaranteed in high-level courses for medical doctors, dentists, veterinarians and pharmacists by institutions that follow the educational standards suggested by the Liga Medicorum Homoeopathica Internationalis (LMHI). Teachers from Argentinean institutions are frequently requested in different countries of the world because of their level of excellence. This shows that Argentinean homeopathy is still valid since the times of Dr. Tomas Pablo Paschero, who was a well-known President of the LMHI. The Federacion de Asociaciones Medicas Homeopaticas Argentinas (FAMHA, or Federation of Argentinean Homeopathic Medical Associations) unites prestigious educational institutions that keep the legacy alive. The FAMHA continues fighting for homeopathy's legal recognition. In that regard, homeopaths are allowed to prescribe homeopathic remedies, but the practice of this therapeutic method has not yet been considered a medical act. Despite being criticized and attacked by conservative groups among the health system, homeopathy in Argentina is appreciated in other health environments and by all the patients who have benefited from this healing methodology.
South & Central America Homeopathy Market Overview
The South & Central America homeopathy market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market is likely to propel during the forecast period owing to the increasing availability and accessibility of homeopathic products and service, the increasing regulatory support by the health authorities ensuring the sale of homeopathic products.
South & Central America Homeopathy Market Revenue and Forecast to 2030 (US$ Million)
South & Central America Homeopathy Market Segmentation
The South & Central America homeopathy market is segmented based on source, type, application, distribution channel, and country. Based on sources, the South & Central America homeopathy market is segmented into plants, animals, and minerals. The plants segment held the largest market share in 2022.
Based on type, the South & Central America homeopathy market is segmented into dilutions, tinctures, biochemics, ointments, tablets, and others. The dilutions segment held the largest market share in 2022.
Based on application, the South & Central America homeopathy market is segmented into analgesic and antipyretic, respiratory, neurology, immunology, gastroenterology, dermatology, and others. The immunology segment held the largest market share in 2022.
Based on distribution channel, the South & Central America homeopathy market is segmented into homeopathic clinics, retail pharmacies, e-retailers, and others. The homeopathic clinics segment held the largest market share in 2022.
Based on country, the South & Central America homeopathy market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America homeopathy market share in 2022.
Fourrts, Boiron, Biologische Heilmittel Heel GmbH, DHU-Arzneimittel GmbH & Co. KG, and Dr Reckeweg & Co GmbH are some of the leading players operating in the South & Central America homeopathy market.